Murphy is a well-respected investor newsletter writer. His claim to fame was making the right call on biotech behemoths Amgen, Biogen, and Genentech (recently bought out by Roche).
http://seekingalpha.com/instablog/128006-michael-murphy/1133-dendreon-a-360-stock-or-is-that-too-low
He's obviously bullish on DNDN, but a peak into his newsletter reveals he's also bullish on MELA and ARNA.
Do your due diligence and good luck.
Disclosure: I am long DNDN and ARNA.
Monday, April 20, 2009
Subscribe to:
Post Comments (Atom)
Posts
![[Most Recent Quotes from www.kitco.com]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_s1pYtwLFH3jD13mSW_BQzx8783vnXzZZSbF5dodJXvf6MPCq6SK-e65tUP9EqSOym0-cUuayOvYh_MHghjYJHj8ZraBDfcMWAdAAkis1oUQ1NbF7adcEB5si4MJ4pUO-hmvg=s0-d)
![[Most Recent Quotes from www.kitco.com]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_u1uDP7YeIyiBK7Ha2WasDlN5OH6TvPVpYOIwJsv8PFDImJLbQrqYdASJe0eT3VcZeb5A22q0guNESUt-9cAkQBIASsJH8fzsz8mN4tnCxdyl6vvsYmx2df0ulLCVmahunu3HS7=s0-d)
![[Most Recent USD from www.kitco.com]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_uwAh9luiXAda7-rr20hJri3a4X2jNraMh9U0sRnlKWdaDQMLK202370C5Z01xieClheAzAMKl0soR5RqtRIFvO78k4JWVnMfKzRrOIudXzfajNsjs4FgMz=s0-d)
No comments:
Post a Comment